Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000950144-03-011967
Filing Date
2003-10-29
Accepted
2003-10-29 17:14:44
Documents
5
Period of Report
2003-09-27

Document Format Files

Seq Description Document Type Size
1 NABI BIOPHARMACEUTICALS g85404a1e10vqza.htm 10-Q/A 344688
3 EX-10.1 LETTER AGREEMENT WITH DAVID J. GURY g85404a1exv10w1.txt EX-10.1 27698
4 EX-31.1 CEO CERT. RULE 13A-14(A)/15D-14A g85404a1exv31w1.htm EX-31.1 6711
5 EX-31.2 CFO CERT. RULE 13A-14(A)/15D-14A g85404a1exv31w2.htm EX-31.2 6605
6 EX-32.1 SECTION 1350 CERTIFICATION OF CEO & CFO g85404a1exv32w1.htm EX-32.1 2645
  Complete submission text file 0000950144-03-011967.txt   390716
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: 10-Q/A | Act: 34 | File No.: 000-04829 | Film No.: 03964409
SIC: 2836 Biological Products, (No Diagnostic Substances)